Unknown

Dataset Information

0

Vaccination with VLPs Presenting a Linear Neutralizing Domain of S. aureus Hla Elicits Protective Immunity.


ABSTRACT: The pore-forming cytotoxin ?-hemolysin, or Hla, is a critical Staphylococcus aureus virulence factor that promotes infection by causing tissue damage, excessive inflammation, and lysis of both innate and adaptive immune cells, among other cellular targets. In this study, we asked whether a virus-like particle (VLP)-based vaccine targeting Hla could attenuate S. aureus Hla-mediated pathogenesis. VLPs are versatile vaccine platforms that can be used to display target antigens in a multivalent array, typically resulting in the induction of high titer, long-lasting antibody responses. In the present study, we describe the first VLP-based vaccines that target Hla. Vaccination with either of two VLPs displaying a 21 amino-acid linear neutralizing domain (LND) of Hla protected both male and female mice from subcutaneous Hla challenge, evident by reduction in lesion size and neutrophil influx to the site of intoxication. Antibodies elicited by VLP-LND vaccination bound both the LND peptide and the native toxin, effectively neutralizing Hla and preventing toxin-mediated lysis of target cells. We anticipate these novel and promising vaccines being part of a multi-component S. aureus vaccine to reduce severity of S. aureus infection.

SUBMITTER: Joyner JA 

PROVIDER: S-EPMC7404987 | biostudies-literature | 2020 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Vaccination with VLPs Presenting a Linear Neutralizing Domain of <i>S. aureus</i> Hla Elicits Protective Immunity.

Joyner Jason A JA   Daly Seth M SM   Peabody Julianne J   Triplett Kathleen D KD   Pokhrel Srijana S   Elmore Bradley O BO   Adebanjo Diane D   Peabody David S DS   Chackerian Bryce B   Hall Pamela R PR  

Toxins 20200711 7


The pore-forming cytotoxin α-hemolysin, or Hla, is a critical <i>Staphylococcus aureus</i> virulence factor that promotes infection by causing tissue damage, excessive inflammation, and lysis of both innate and adaptive immune cells, among other cellular targets. In this study, we asked whether a virus-like particle (VLP)-based vaccine targeting Hla could attenuate <i>S. aureus</i> Hla-mediated pathogenesis. VLPs are versatile vaccine platforms that can be used to display target antigens in a mu  ...[more]

Similar Datasets

| S-EPMC4910727 | biostudies-literature
| S-EPMC3019872 | biostudies-other
| S-EPMC4030048 | biostudies-literature
| S-EPMC5540943 | biostudies-other
| S-EPMC2925461 | biostudies-literature
| S-EPMC3348682 | biostudies-literature
| S-EPMC5768464 | biostudies-literature
| S-EPMC9798903 | biostudies-literature
| S-EPMC5010209 | biostudies-literature
| S-EPMC5555299 | biostudies-other